Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1994-08-05
1996-04-30
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424 121, 436829, A61K 9127
Patent
active
055122949
ABSTRACT:
Polymerized liposome particles based upon lipids having a polymerizable functional group and a metal chelator to attach an imaging enhancement agent and lipids having an active targeting group to provide targeted polymerized liposome contrast agents. The polymerized imaging enhancement liposome particles interact with receptor targets holding the image enhancement agent to specific sites providing in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology.
REFERENCES:
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4938947 (1990-07-01), Nicolau et al.
patent: 5017359 (1991-05-01), Nicolau et al.
patent: 5077057 (1991-12-01), Szoka, Jr.
patent: 5078986 (1992-01-01), Bosworth et al.
patent: 5135737 (1992-08-01), Keana
patent: 5158760 (1992-10-01), Phillips et al.
patent: 5213804 (1993-05-01), Martin et al.
patent: 5246707 (1993-09-01), Haynes
patent: 5277914 (1994-01-01), Szoka, Jr.
patent: 5366881 (1994-11-01), Singth
patent: 5387410 (1995-02-01), Bosworth
patent: 5395619 (1995-03-01), Zalipsky
Purnima Pinnaduwage and Leaf Haung, "Stable Target-Sensitive Immunoliposomes", Biochemistry (1992), 31, 2850-2855.
Marja-Leena Laukkanen, Kaija Alfthan, and Kari Keinanen, "Functional Immunoliposomes Harboring a Biosynthetically Lipid-Tagged Single-Chain Antibody", Biochemistry (1994), 33, 11664-11670.
Unger, E. C., Shen, D. K., and Fritz, T. A., Status of Liposomes as MR Contrast Agents, JMRI, 3, 195-198, (1993).
Gore, J. C. and Smith, F. W., Special Issue: Contrast Agents, Magn. Reson. Img., 3, 1-97, (1985).
Hasso, A. N. and Stark, D. D., Special Issue: Contrast Agents, JMRI, 3, 137-310, (1993).
Wehrli, F. W., SMRM Workshop: Contrast Enhanced Magnetic Resonance, Magn. Reson. Med., 22, 177-378, (1991).
Reimer, P., Weissleder, R. Brady, T. J., Baldwin, B. H., Tennant, B. C., and Wittenberg, J., Experimental Hepatocellular Carcinoma: MR Receptor Imaging, Radiology, 180, 641-645 (1991).
Reimer, P., Weisslender, R., Lee, A. S., and Brady, T. J., Receptor Imaging: Application to MR Imaging of Liver Cancer, Radiology, 177, 729-734 (1990).
Reimer, P., Weissleder, R., Wittenberg, J., and Brady, T. J., Receptor-Directed Contrast Agents for MR Imaging: Preclinical Evaluation With Affinity Assays, Radiology, 182, 565-569 (1992).
Weissleder, R., Reimer, P., Lee, A. S., Wittenberg, J. and Brady T. J., MR Receptor Imaging: Ultrasmall Iron Oxide Particles Targeted to Asialoglycoprotein Receptors, AJR, 155, 1161-67, (1990).
Unger, E. C., Totty, W. G., Neufeld, D. M., Otsuka, F. L., Murphy, W. A., Welch, M. S., Connett, J. M., and Philpott, G. W., Magnetic Resonance Imaging Using Gadolinium labeled Monoclonal Antibody, Invest. Radiol., 20, 693-700. (1985).
Weissleder, R., Lee, A. S., Fischman, A. J., Reimer, P., Shen, T., Wilkinson, R., Callahan, R. J., and Brady, T. J., Polyclonal Human Immunoglobulin G Labeled with polymeric Iron Oxide: Antibody MR Imaging, Radiology, 181, 245-249, (1991).
Bednarski Mark D.
Kuniyoshi Jeremy K.
Li Henry Y.
Li King C.
Sipkins Dorothy A.
LandOfFree
Targeted polymerized liposome contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted polymerized liposome contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted polymerized liposome contrast agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-626670